Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H15ClN4O2 |
Molecular Weight | 270.715 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC1=CC=C(Cl)N=C1)C(\NC)=C\[N+]([O-])=O
InChI
InChIKey=CFRPSFYHXJZSBI-DHZHZOJOSA-N
InChI=1S/C11H15ClN4O2/c1-3-15(11(13-2)8-16(17)18)7-9-4-5-10(12)14-6-9/h4-6,8,13H,3,7H2,1-2H3/b11-8+
DescriptionSources: https://www.drugs.com/pro/capstar.htmlCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12012747 | https://www.ncbi.nlm.nih.gov/pubmed/12208819 | https://www.ncbi.nlm.nih.gov/pubmed/12814666
Sources: https://www.drugs.com/pro/capstar.html
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12012747 | https://www.ncbi.nlm.nih.gov/pubmed/12208819 | https://www.ncbi.nlm.nih.gov/pubmed/12814666
Nitenpyram is a neonicotinoid, a neurotoxin that blocks neural messages and used in agriculture and veterinary medicine to kill external parasites of pets. Imidacloprid act as agonists at the insect nicotinic acetylcholine receptor (nAChR). The botanical insecticide nicotine acts at the same target without the neonicotinoid level of effectiveness or safety. Fundamental differences between the nAChRs of insects and mammals confer remarkable selectivity for the neonicotinoids. Whereas ionized nicotine binds at an anionic subsite in the mammalian nAChR, the negatively tipped ("magic" nitro or cyano) neonicotinoids interact with a proposed unique subsite consisting of cationic amino acid residue(s) in the insect nAChR. Nitenpyram was introduced into the United States in 1994 as a veterinary flea control treatment, structural pest and crop insecticide, and seed treatment. It has been used orally in dogs, cats, and some wildlife species for over 10 years. After ingestion, it begins killing adult fleas within 30 minutes, and effects continue for up to 48 hours. Though nitenpyram is used to kill adult fleas quickly on an infected animal, it does not kill insect eggs and has no long-term activity. Thus, it is not effective as a long-term flea preventative; however, it can be repeatedly applied over the course of several days to eradicate a single instance of infestation. Nitenpyram can be combined with a longer-term flea preventative like fipronil or lufenuron to prevent reinfestation. Neonicotinoids for veterinary use are considered to have a low order of toxicity for domestic animals and there are no reports of nitenpyram intoxication.
Originator
Sources: https://encrypted.google.com/patents/EP0392560B1
Curator's Comment: # Takeda Chemical Industries, Ltd
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3350223 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10936213 |
11.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | capstar Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/capstar.html
For dogs and cats -- 11.4-57mg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12814666
Xenopus laevis oocytes were used for activity evaluation. Stock solutions of imidacloprid (1 mM), CH-IMI (10 mM), DN-IMI (10 mM) and nitenpyram (100 mM) in SOS were stored at 4 C. To suppress any possible endogenous muscarinic response, saline containing 0.5 M atropine was employed. Using two-electrode voltage-clamp electrophysiology, membrane currents were recorded by a GENECLAMP 500B (Axon Instruments, Union City, CA, USA) amplifier at a membrane potential of -100 mV. Current signals were displayed on a pen recorder. Oocytes were challenged with test compounds at intervals of 3–5 min to minimize effects of desensitization. Concentration-response data were obtained, not only by challenging oocytes with increasing concentrations of either ACh or neonicotinoid, but also by deploying decreasing concentrations of the compounds under test in order to confirm the validity of the concentration-response curve. The maximum amplitude of the current recorded in response to each challenge was normalized to the maximum amplitude of the current response to ACh
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C737
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
||
|
WHO-VATC |
QP53BX02
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
||
|
CFR |
21 CFR 520.1510
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C80604
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
m7924
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
nitenpyram
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
C464843
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
DTXSID8041080
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
3034287
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
341379
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
300000023686
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
3A837VZ81Y
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
150824-47-8
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
NITENPYRAM
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
DB11438
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
3A837VZ81Y
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY | |||
|
39170
Created by
admin on Fri Dec 15 16:06:41 GMT 2023 , Edited by admin on Fri Dec 15 16:06:41 GMT 2023
|
PRIMARY |
ACTIVE MOIETY